Carotid body chemoreflex: a driver of autonomic abnormalities in sleep apnoea

Experimental Physiology

Volumn 101, Issue 8, 2016, Pages 975-985

  Prabhakar, Nanduri R ^a  

^a University of Chicago   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ANGIOTENSIN II; ANTIOXIDANT; CALCIUM ION; CALPAIN; CATECHOLAMINE; CYSTATHIONINE GAMMA LYASE; ENDOTHELIN 1; ENZYME; HEME OXYGENASE 2; HYDROGEN SULFIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; SEROTONIN;

ADRENAL MEDULLA; APNEA; ARTERIAL OXYGEN TENSION; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE; BRAIN NERVE CELL; BRAIN STEM; BREATHING; CAROTID BODY CHEMORECEPTOR; CAROTID SINUS NERVE; CENTRAL SLEEP APNEA SYNDROME; CHEMORECEPTOR REFLEX; COMORBIDITY; ELEVATED BLOOD PRESSURE; HUMAN; HYPERTENSION; INTERMITTENT HYPOXIA; NEWBORN APNEA; NONHUMAN; OXIDATION REDUCTION STATE; POSITIVE END EXPIRATORY PRESSURE; REVIEW; RODENT MODEL; ROSTRAL VENTROLATERAL MEDULLA; SLEEP DISORDERED BREATHING; SOLITARY TRACT NUCLEUS; SYMPATHETIC TONE;

EID: 84982965927     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/EP085624     Document Type: Review

References (94)

1. Ambrosio G, Zweier JL, Duilio C, Kuppusamy P, Santoro G, Elia PP, Tritto I, Cirillo P, Condorelli M & Chiariello M (1993). Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J Biol Chem 268, 18532–18541.
2. Bachoo M & Polosa C (1985). Properties of a sympatho-inhibitory and vasodilator reflex evoked by superior laryngeal nerve afferents in the cat. J Physiol 364, 183–198.
3. Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J & Wallin BG (1993). Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 103, 1763–1768.
4. Carreau A, El Hafny-Rahbi B, Matejuk A, Grillon C & Kieda C (2011). Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. J Cell Mol Med 15, 1239–1253.
5. Carulli D, Foscarin S & Rossi F (2011). Activity-dependent plasticity and gene expression modifications in the adult CNS. Front Mol Neurosci 4, 50.
6. Cistulli PA & Sullivan CE (1994). Pathophysiology of sleep apnea. In Sleep and Breathing, ed. Saunders NA & Sullivan CE, pp. 405–448. Dekker, New York.
7. Costa-Silva JH, Zoccal DB & Machado BH (2012). Chronic intermittent hypoxia alters glutamatergic control of sympathetic and respiratory activities in the commissural NTS of rats. Am J Physiol Regul Integr Comp Physiol 302, R785–R793.
8. Dampney RA (1994). Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 74, 323–364.
9. de Burgh Daly M (1985). Chemoreceptor reflexes and cardiovascular control. Acta Physiol Pol 36, 4–20.
10. de Burgh Daly M, Lambertsen CJ & Schweitzer A (1954). Observations on the volume of blood flow and oxygen utilization of the carotid body in the cat. J Physiol 125, 67–89.
11. Del Rio R, Muñoz C, Arias P, Court FA, Moya EA & Iturriaga R (2011). Chronic intermittent hypoxia-induced vascular enlargement and VEGF upregulation in the rat carotid body is not prevented by antioxidant treatment. Am J Physiol Lung Cell Mol Physiol 301, L702–L711.
12. Dempsey JA, Sheel AW, St Croix CM & Morgan BJ (2002). Respiratory influences on sympathetic vasomotor outflow in humans. Respir Physiol Neurobiol 130, 3–20.
13. Dempsey JA, Veasey SC, Morgan BJ & O'Donnell CP (2010). Pathophysiology of sleep apnea. Physiol Rev 90, 47–112.
14. de Paula PM, Tolstykh G & Mifflin S (2007). Chronic intermittent hypoxia alters NMDA and AMPA-evoked currents in NTS neurons receiving carotid body chemoreceptor inputs. Am J Physiol Regul Integr Comp Physiol 292, R2259–R2265.
15. Dudenbostel T & Calhoun DA (2012). Resistant hypertension, obstructive sleep apnea and aldosterone. J Hum Hypertens 26, 281–287.
16. Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y & Fujii-Kuriyama Y (1997). A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA 94, 4273–4278.
17. Feinberg AP (2007). Phenotypic plasticity and the epigenetics of human disease. Nature 447, 433–440.
18. 2+ signaling networks in regulating gene expression by action potentials. Cell Calcium 37, 433–442.
19. Fletcher EC (1995). An animal model of the relationship between systemic hypertension and repetitive episodic hypoxia as seen in sleep apnea. J Sleep Res 4, 71–77.
20. Fletcher EC, Lesske J, Behm R, Miller CC 3rd, Stauss H & Unger T (1992). Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea. J Appl Physiol 72, 1978–1984.
21. Fletcher EC, Miller J, Schaaf JW & Fletcher JG (1987). Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 10, 35–44.
22. Ganguly K & Poo MM (2013). Activity-dependent neural plasticity from bench to bedside. Neuron 80, 729–741.
23. García-Río F, Racionero MA, Pino JM, Martínez I, Ortuño F, Villasante C & Villamor J (2000). Sleep apnea and hypertension. Chest 117, 1417–1425.
24. Gorąca A, Kleniewska P & Skibska B (2016). ET-1 mediates the release of reactive oxygen species and TNF-α in lung tissue by protein kinase C α and β1. Pharmacol Rep 68, 121–126.
25. Guyenet PG (2000). Neural structures that mediate sympathoexcitation during hypoxia. Respir Physiol 121, 147–162.
26. Haselton JR & Guyenet PG (1989). Central respiratory modulation of medullary sympathoexcitatory neurons in rat. Am J Physiol Regul Integr Comp Physiol 256, R739–R750.
27. Hedner JA, Wilcox I, Laks L, Grunstein RR & Sullivan CE (1992). A specific and potent pressor effect of hypoxia in patients with sleep apnea. Am Rev Respir Dis 146, 1240–1245.
28. Hibbs AM, Johnson NL, Rosen CL, Kirchner HL, Martin R, Storfer-Isser A & Redline S (2008). Prenatal and neonatal risk factors for sleep disordered breathing in school-aged children born preterm. J Pediatr 153, 176–182.
29. Huang J, Lusina S, Xie T, Ji E, Xiang S, Liu Y & Weiss JW (2009). Sympathetic response to chemostimulation in conscious rats exposed to chronic intermittent hypoxia. Respir Physiol Neurobiol 166, 102–106.
30. Illingworth RS & Bird AP (2009). CpG islands – ‘a rough guide’. FEBS Lett 583, 1713–1720.
31. Iturriaga R (2013). Intermittent hypoxia: endothelin-1 and hypoxic carotid body chemosensory potentiation. Exp Physiol 98, 1550–1551.
32. Kara T, Narkiewicz K & Somers VK (2003). Chemoreflexes – physiology and clinical implications. Acta Physiol Scand 177, 377–384.
33. Khan SA, Nanduri J, Yuan G, Kinsman B, Kumar GK, Joseph J, Kalyanaraman B & Prabhakar NR (2011). NADPH oxidase 2 mediates intermittent hypoxia-induced mitochondrial complex I inhibition: relevance to blood pressure changes in rats. Antioxid Redox Signal 14, 533–542.
34. 2+ concentration in rat carotid body glomus cells. Respir Physiol Neurobiol 215, 30–38.
35. Kline DD, Ramirez-Navarro A & Kunze DL (2007). Adaptive depression in synaptic transmission in the nucleus of the solitary tract after in vivo chronic intermittent hypoxia: evidence for homeostatic plasticity. J Neurosci 27, 4663–4673.
36. Kumar GK, Rai V, Sharma SD, Ramakrishnan DP, Peng YJ, Souvannakitti D & Prabhakar NR (2006). Chronic intermittent hypoxia induces hypoxia-evoked catecholamine efflux in adult rat adrenal medulla via oxidative stress. J Physiol 575, 229–239.
37. Kumar P & Prabhakar NR (2012). Peripheral chemoreceptors: function and plasticity of the carotid body. Compr Physiol 2, 141–219.
38. Kuri BA, Khan SA, Chan SA, Prabhakar NR & Smith CB (2007). Increased secretory capacity of mouse adrenal chromaffin cells by chronic intermittent hypoxia: involvement of protein kinase C. J Physiol 584, 313–319.
39. Lam SY, Liu Y, Ng KM, Lau CF, Liong EC, Tipoe GL & Fung ML (2012). Chronic intermittent hypoxia induces local inflammation of the rat carotid body via functional upregulation of proinflammatory cytokine pathways. Histochem Cell Biol 137, 303–317.
40. Lavie P, Herer P & Hoffstein V (2000). Obstructive sleep apnea syndrome as a risk factor for hypertension: population study. BMJ 320, 479–482.
41. Lesske J, Fletcher EC, Bao G & Unger T (1997). Hypertension caused by chronic intermittent hypoxia – influence of chemoreceptors and sympathetic nervous system. J Hypertens 15, 1593–1603.
42. Li Q, Sun B, Wang X, Jin Z, Zhou Y, Dong L, Jiang LH & Rong W (2010). A crucial role for hydrogen sulfide in oxygen sensing via modulating large conductance calcium-activated potassium channels. Antioxid Redox Signal 12, 1179–1189.
43. Longobardo GS, Gothe B, Goldman MD & Cherniack NS (1982). Sleep apnea considered as a control system instability. Respir Physiol 50, 311–333.
44. McAllen RM (1987). Central respiratory modulation of subretrofacial bulbospinal neurones in the cat. J Physiol 388, 533–545.
45. Marrone O, Riccobono L, Salvaggio A, Mirabella A, Bonanno A & Bonsignore MR (1993). Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest 103, 722–727.
46. Miyawaki T, Pilowsky P, Sun QJ, Minson J, Suzuki S, Arnolda L, Llewellyn-Smith I & Chalmers J (1995). Central inspiration increases barosensitivity of neurons in rat rostral ventrolateral medulla. Am J Physiol Regul Integr Comp Physiol 268, R909–R918.
47. Moraes DJA, da Silva MP, Bonagamba LGH, Mecawi AS, Zoccal DB, Antunes-Rodrigues J, Varanda WA & Machado BH (2013). Electrophysiological properties of rostral ventrolateral medulla presympathetic neurons modulated by the respiratory network in rats. J Neurosci 33, 19223–19237.
48. Moraes DJA, Machado BH & Paton JFR (2015). Carotid body overactivity induces respiratory neurone channelopathy contributing to neurogenic hypertension. J Physiol 593, 3055–3063.
49. Mulgrew AT, Lawati NA, Ayas NT, Fox N, Hamilton P, Cortes L & Ryan CF (2010). Residual sleep apnea on polysomnography after 3 months of CPAP therapy: clinical implications, predictors and patterns. Sleep Med 11, 119–125.
50. Nanduri J, Makarenko V, Reddy VD, Yuan G, Pawar A, Wang N, Khan SA, Zhang X, Kinsman B, Peng Y-J, Kumar GK, Fox AP, Godley LA, Semenza GL & Prabhakar NR (2012). Epigenetic regulation of hypoxic sensing disrupts cardiorespiratory homeostasis. Proc Natl Acad Sci USA 109, 2515–2520.
51. Nanduri J, Vaddi DR, Khan SA, Wang N, Makerenko V & Prabhakar NR (2013). Xanthine oxidase mediates hypoxia-inducible factor-2α degradation by intermittent hypoxia. PLoS One 8, e75838.
52. Nanduri J, Wang N, Yuan G, Khan SA, Souvannakitti D, Peng YJ, Kumar GK, Garcia JA & Prabhakar NR (2009). Intermittent hypoxia degrades HIF-2α via calpains resulting in oxidative stress: implications for recurrent apnea-induced morbidities. Proc Natl Acad Sci USA 106, 1199–1204.
53. Narkiewicz K & Somers VK (1997). The sympathetic nervous system and obstructive sleep apnea: implications for hypertension. J Hypertens 15, 1613–1619.
54. Narkiewicz K, van de Borne PJ, Pesek CA, Dyken ME, Montano N & Somers VK (1999). Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 99, 1183–1189.
55. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD & Pickering TG (2000). Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283, 1829–1836.
56. Nock ML, Difiore JM, Arko MK & Martin RJ (2004). Relationship of the ventilatory response to hypoxia with neonatal apnea in preterm infants. J Pediatr 144, 291–295.
57. Paavonen EJ, Strang-Karlsson S, Räikkönen K, Heinonen K, Pesonen AK, Hovi P, Andersson S, Järvenpää AL, Eriksson JG & Kajantie E (2007). Very low birth weight increases risk for sleep-disordered breathing in young adulthood: the Helsinki Study of Very Low Birth Weight Adults. Pediatrics 120, 778–784.
58. Pawar A, Peng Y-J, Jacono FJ & Prabhakar NR (2008). Comparative analysis of neonatal and adult rat carotid body responses to chronic intermittent hypoxia. J Appl Physiol 104, 1287–1294.
59. 2 sensing mediate hypertension and pulmonary edema. Proc Natl Acad Sci USA 111, 1174–1179.
60. 2 sensing in the carotid body. Proc Natl Acad Sci USA 107, 10719–10724.
61. Peng Y-J, Nanduri J, Khan SA, Yuan G, Wang N, Kinsman B, Vaddi DR, Kumar GK, Garcia JA, Semenza GL & Prabhakar NR (2011a). Hypoxia-inducible factor 2α (HIF-2α) heterozygous-null mice exhibit exaggerated carotid body sensitivity to hypoxia, breathing instability, and hypertension. Proc Natl Acad Sci USA 108, 3065–3070.
62. Peng Y-J, Nanduri J, Raghuraman G, Wang N, Kumar GK & Prabhakar NR (2013). Role of oxidative stress-induced endothelin-converting enzyme activity in the alteration of carotid body function by chronic intermittent hypoxia. Exp Physiol 98, 1620–1630.
63. Peng Y-J, Nanduri J, Yuan G, Wang N, Deneris E, Pendyala S, Natarajan V, Kumar GK & Prabhakar NR (2009). NADPH oxidase is required for the sensory plasticity of the carotid body by chronic intermittent hypoxia. J Neurosci 29, 4903–4910.
64. Peng Y-J, Overholt JL, Kline D, Kumar GK & Prabhakar NR (2003). Induction of sensory long-term facilitation in the carotid body by intermittent hypoxia: implications for recurrent apneas. Proc Natl Acad Sci USA 100, 10073–10078.
65. Peng Y-J & Prabhakar NR (2004). Effect of two paradigms of chronic intermittent hypoxia on carotid body sensory activity. J Appl Physiol 96, 1236–1242; discussion 1196.
66. Peng Y-J, Raghuraman G, Khan SA, Kumar GK & Prabhakar NR (2011b). Angiotensin II evokes sensory long-term facilitation of the carotid body via NADPH oxidase. J Appl Physiol 111, 964–970.
67. Peng Y-J, Rennison J & Prabhakar NR (2004). Intermittent hypoxia augments carotid body and ventilatory response to hypoxia in neonatal rat pups. J Appl Physiol 97, 2020–2025.
68. Peng Y-J, Yuan G, Jacono FJ, Kumar GK & Prabhakar NR (2006a). 5-HT evokes sensory long-term facilitation of rodent carotid body via activation of NADPH oxidase. J Physiol 576, 289–295.
69. Peng Y-J, Yuan G, Khan S, Nanduri J, Makarenko VV, Reddy VD, Vasavda C, Kumar GK, Semenza GL & Prabhakar NR (2014b). Regulation of hypoxia-inducible factor-α isoforms and redox state by carotid body neural activity in rats. J Physiol 592, 3841–3858.
70. Peng Y-J, Yuan G, Ramakrishnan D, Sharma SD, Bosch-Marce M, Kumar GK, Semenza GL & Prabhakar NR (2006b). Heterozygous HIF-1α deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol 577, 705–716.
71. Peppard PE, Young T, Barnet JH, Palta M, Hagen EW & Hla KM (2013). Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177, 1006–1014.
72. Peppard PE, Young T, Palta M & Skatrud J (2000). Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342, 1378–1384.
73. Prabhakar NR (2001). Oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms. J Appl Physiol 90, 1986–1994.
74. Prabhakar NR (2013). Sensing hypoxia: physiology, genetics and epigenetics. J Physiol 591, 2245–2257.
75. Prabhakar NR & Semenza GL (2012). Adaptive and maladaptive cardiorespiratory responses to continuous and intermittent hypoxia mediated by hypoxia-inducible factors 1 and 2. Physiol Rev 92, 967–1003.
76. Prabhakar NR & Semenza GL (2015). Oxygen sensing and homeostasis. Physiology (Bethesda) 30, 340–348.
77. Reeves SR, Gozal E, Guo SZ, Sachleben LR Jr, Brittian KR, Lipton AJ & Gozal D (2003). Effect of long-term intermittent and sustained hypoxia on hypoxic ventilatory and metabolic responses in the adult rat. J Appl Physiol 95, 1767–1774.
78. Rey S, Del Rio R, Alcayaga J & Iturriaga R (2004). Chronic intermittent hypoxia enhances cat chemosensory and ventilatory responses to hypoxia. J Physiol 560, 577–586.
79. Rey S, Del Rio R & Iturriaga R (2006). Contribution of endothelin-1 to the enhanced carotid body chemosensory responses induced by chronic intermittent hypoxia. Brain Res 1086, 152–159.
80. Solin P, Roebuck T, Johns DP, Walters EH & Naughton MT (2000). Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure. Am J Respir Crit Care Med 162, 2194–2200.
81. Somers VK, Dyken ME, Clary MP & Abboud FM (1995). Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96, 1897–1904.
82. Souvannakitti D, Kumar GK, Fox A & Prabhakar NR (2009). Neonatal intermittent hypoxia leads to long-lasting facilitation of acute hypoxia-evoked catecholamine secretion from rat chromaffin cells. J Neurophysiol 101, 2837–2846.
83. 2+ channels and ryanodine receptors mediate the augmented exocytosis of catecholamines from intermittent hypoxia-treated neonatal rat chromaffin cells. J Neurosci 30, 10763–10772.
84. Stornetta RL, Sevigny CP, Schreihofer AM, Rosin DL & Guyenet PG (2002). Vesicular glutamate transporter DNPI/VGLUT2 is expressed by both C1 adrenergic and nonaminergic presympathetic vasomotor neurons of the rat medulla. J Comp Neurol 444, 207–220.
85. Tafil-Klawe M, Thiele AE, Raschke F, Mayer J, Peter JH & von Wichert W (1991). Peripheral chemoreceptor reflex in obstructive sleep apnea patients; a relationship between ventilatory response to hypoxia and nocturnal bradycardia during apnea events. Pneumologie 45 Suppl 1, 309–311.
86. Tamisier R, Pépin JL, Rémy J, Baguet JP, Taylor JA, Weiss JW & Lévy P (2011). 14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans. Eur Respir J 37, 119–128.
87. Ca channels. Respir Physiol Neurobiol 172, 169–178.
88. Thomas RJ, Terzano MG, Parrino L & Weiss JW (2004). Obstructive sleep-disordered breathing with a dominant cyclic alternating pattern–a recognizable polysomnographic variant with practical clinical implications. Sleep 27, 229–234.
89. Tian H, McKnight SL & Russell DW (1997). Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 11, 72–82.
90. Yuan G, Adhikary G, McCormick AA, Holcroft JJ, Kumar GK & Prabhakar NR (2004). Role of oxidative stress in intermittent hypoxia-induced immediate early gene activation in rat PC12 cells. J Physiol 557, 773–783.
91. Yuan G, Khan SA, Luo W, Nanduri J, Semenza GL & Prabhakar NR (2011). Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia. J Cell Physiol 226, 2925–2933.
92. 2+ signaling, prolyl hydroxylases, and mTOR. J Cell Physiol 217, 674–685.
93. 2S governs oxygen sensing. Sci Signal 8, ra37.
94. Zhan G, Serrano F, Fenik P, Hsu R, Kong L, Pratico D, Klann E & Veasey SC (2005). NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care Med 172, 921–929.